NCT00335725View on ClinicalTrials.gov

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Infertility
Interventions
DRUG

Follicle Stimulating Hormone

subcutaneous injection of FSH. Starting dose: 225 IU.

DRUG

Follicle Stimulating Hormone

subcutaneous injection of FSH. Starting dose: 225 IU.

Trial Locations (7)

Unknown

Private Consulting, Bron

Hôpital Jeanne de Flandre, Lille

Hôpital Edouard Herriot, Lyon

Institut de Médecine de la Reproduction, Marseille

Hôpital Américain, Neuilly-sur-Seine

Hôpital Tenon, Paris

Semmelweis Medical School, Budapest

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT00335725 - Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI. | Biotech Hunter | Biotech Hunter